Related Experiment Video

Updated: Aug 23, 2026

In Vitro Scratch Assay to Demonstrate Effects of Arsenic on Skin Cell Migration
09:24

In Vitro Scratch Assay to Demonstrate Effects of Arsenic on Skin Cell Migration

Published on: February 23, 2019

Understanding arsenic carcinogenicity by the use of animal models

Hideki Wanibuchi1, Elsayed I Salim, Anna Kinoshita

  • 1Department of Pathology, Osaka City University Medical School, Osaka 545-8585, Japan. wani@med.osaka-cu.ac.jp

Toxicology and Applied Pharmacology
|July 28, 2004
PubMed

Insights

Dimethylarsinic acid (DMA), a major arsenic metabolite, is a potent clastogenic agent. Animal studies show DMA and related compounds initiate and promote various cancers, suggesting complex carcinogenic mechanisms.

Area of Science:

  • Toxicology
  • Carcinogenesis
  • Environmental Health

Background:

  • Epidemiological studies link human arsenic exposure to increased cancer risk.
  • Dimethylarsinic acid (DMA) is a primary mammalian metabolite of inorganic arsenic.
  • In vitro studies identify DMA as a potent clastogenic agent causing DNA damage.

Purpose of the Study:

  • To investigate the carcinogenicity of DMA and its metabolites in animal models.
  • To elucidate the mechanisms by which DMA contributes to cancer development.
  • To review existing data on DMA's role in arsenic-induced carcinogenesis.

Main Methods:

  • Multi-organ promotion bioassays in rats.
  • Two-stage carcinogenesis bioassays in rats (urinary bladder, liver).
  • Long-term carcinogenicity tests (2-year) in rats and transgenic mice.
  • Studies in genetically modified mice (p53, OGG1).

Main Results:

  • DMA and related organic arsenicals demonstrated both initiating and promoting effects on carcinogenesis.
  • Adverse effects were observed across multiple organs, including liver, skin, bladder, and lungs.
  • Carcinogenic potential was confirmed in various rat and mouse models.

Conclusions:

  • DMA and its metabolites play a significant role in arsenic carcinogenesis.
  • Multiple mechanisms are likely involved in DMA-induced cancer.
  • Animal models are crucial for understanding arsenic carcinogenicity mechanisms.

More Related Videos

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)

Published on: December 19, 2019

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...